Rakuten Medical
Developer of precision-targeted cancer therapies designed to treat solid tumors. The company's therapies consist of a cancer-targeting monoclonal antibody conjugated to a photoactivatable molecule to ...
Valuation
$0
Share Price
N/A
Total Raised
$775.6M
Last Round
N/A